Subscribe

0

Syngene International

Syngene InFocus

Syngene Reports 11% Rise in Q1 FY26 Operating Revenue

Syngene International reports strong Q1 FY26 results: 11% revenue growth, 19% EBITDA increase, and 59% PAT jump. Positive outlook for the year ahead!

By SMEStreet Edit Desk
Jul 24, 2025 10:49 IST 2 Min read
Peter Bains InFocus
Syngene Announces Leadership Change: Peter Bains Appointed CEO
By SMEStreet Edit Desk
Feb 11, 2025 14:35 IST 1 Min read
Stock Market, Demat Accounts, NSE, BSE, Sensex, NIFTY InFocus
Syngene International Sustained Positive Performance in Fourth Quarter Delivers Strong Full Year Results
By SMEStreet Edit Desk
Apr 27, 2023 03:25 IST 6 Min read
Jonathan Hunt, Syngene InFocus
Syngene Reported 10% Growth in Revenue to Rs. 6414 Mn
By SMEStreet Edit Desk
Jan 20, 2022 06:39 IST 3 Min read
Jonathan Hunt, Syngene Sectors
Syngene Expands Biopharma-Manufacturing Capacity
By SMEStreet Edit Desk
Aug 12, 2021 10:51 IST 2 Min read
Remdesivir Injection, News
Remdesivir Injection's Price Reduced, Here are the New Prices
By SMEStreet Edit Desk
Apr 19, 2021 05:42 IST 1 Min read